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Abs tract
In its simplestfo rm, the serotonin deficiency theoryofdepression postulates that there is a net
reduction in serotonin transmission in depressive illness. The pathophy siological change may result
fr om two different mechanisms. Thejirst involves a decrease in serotonin (5-H T) availability which
has the consequential tiffict ofcompensatory receptor up-regulation or supersensitiuity. The second
mechanism impliesa primary defect in receptor activity and/ orsignal transduction. Theobjectioeqf
this review is to analyze the serotonin system in depression as it relates to the above twopostulates.
Chemical imbalances in th e ce nt ral nervous syste m (CNS) have long been
th ou ght to underlie fluctuations in mood . The a mine hypothesis, th a t t he pat hop hysi-
ology of depress ion involves impairment of ca techo la mines, has been expanded to
include th e rol e of sero tonin, or 5-hyd roxyt ryp to phan (5-HT). Through its wide-
spre ad distribution within th e neural axis, se ro tonin is th ou gh t to: "playa key ro le in
th e modulation of excessive st im uli of a wid e va rie ty a nd in the orga nization of
appro pria te responses. It has been sugges te d th at th e overall fu nction of th e
se ro to nine rg ic syste m is to enable th e organism to wa rd of feeli ngs of fear, helpless-
ness and depression ( I )." Con sist ent with this hypoth esis is the evide nce th a t
alte ra t ions in se ro tonin acti vit y have a rol e in co re beh aviors which are also disturbed
in a ffec tive illn ess ( 1,2) .
In it s sim ples t form, th e se ro to nin deficien cy theory of depression postu lat es
th at th ere is a net reducti on in se ro to nin tran smi ssion in depressive illn ess. The
pathophysiological cha nge may result from two di fferen t mechanisms. The first
involv es a decrease in 5-HT ava ilability which has th e conseq ue nt ia l effect of
com pe nsa tory receptor up-regul ation or supersen sitivit y. The second mechani sm
implies a prima ry defect in receptor ac tivity and / or signa l tran sducti on . Alt ho ugh
th e se rotonin deficien cy th eory receives conside rable suppo r t in exp lanat ions of
depression, recent stud ies have sug ge ste d that some forms of human depression ma y
be du e to an exce ss of serotonin at th e synapse (3) . The objective of th e following
review is to a na lyze th e se ro to nin syste m in depression as it relat es to the above two
postulates.
The searc h for th e role of se ro to nin in depression has evolved from resea rch on
depression-related a lte rat ions in seroto nin levels, to cha nge s in 5-HT metabolism
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and more recently to 5-HT receptor stud ies. In t he following review, th e dat a will be
described in a similar sequen ce. It is important to not e th a t this disc ussion will
include references to cont rad ict ions in experime ntal results. In part , this com plexity
reflect s th e challe nge in isol ating the ac t ion(s) of se ro to nin given it s d ist ribu t ion in
fun ctionally di scr et e regions of th e C NS (4). Furthermore, se ro to nin medi at es a
diverse a rray of ph ysiological respons es by interacting with seve ra l d ifferent 5-HT
receptor subtypes as well as int er acting with th e act ions of several non serot oniner gic
syst ems (5,6) . The challenge in research , th erefore, is to isolate th e act ion s of 5-HT,
as well as th e effect ive ne ss of drugs on this syste m, given th e diversity in serotonin
di stribution as well as the het erogen eity of 5-HT receptors. W ith regard to the
clinical findings, in pa rt th e contradict ion in results reflect s th e d ifficulty in compar-
ing individuals based on a subject ive assessme n t of sym ptomato logy despite the
possibility of different diagnosti c subg ro ups, associa ted et iologies and / or trea tment
exposure (s). This review will a tt empt to describe th e ro le of serotonin whil e acknowl-
edging th e m ethodological difficulties and con t rad ict ions in find ings.
CSF AND BRAIN LEVELS O F 5-HT AND 5-HIAA
The ea rl iest studies whi ch focu sed on th e rol e of serotonin in depr ession
measured th e ce re brospinal fluid (CSF) concen t ra t ion of se ro tonin or its major
met abolit e, 5-hyd roxyindoleace t ic acid (5-HIAA), as a n index of se ro to ninergic
ac t ivity . In humans , th e level of CS F 5-HlAA has been found to corre la te accura te ly
with th e conce ntra tion of 5-H IAA in th e brain (7). Alt ho ug h some st udies have fou nd
decr eased levels of th e serotonin met ab olite in depressed pa tien ts ot he rs have fa iled
to report significant differen ces when compared to normal cont rols (8,9, 10). Interest -
ingly, a n t ide pressan t treatm ent with drugs whi ch in hib it 5-HT upt a ke (e.g. imipra-
mi ne, a mitrip tyline) decr ease th e CS F 5-HIAA level altho ugh th e magnitude of the
redu cti on does not co rrela te with the clinica l respon siveness to medicat ion ( I I). This
action is pr ed icted based on feedba ck effects involving incr eased post -syna pt ic
act ivity and up tak e with a subsequen t decr ease in serotonin .
In contrast to the above stu dies which focu sed on th e depressed patient , CSF
studies of suicide a ttempte rs repor t significa nt reducti ons in 5-H IAA (12). Mor eover,
suicide vict ims wit h definit ive affective disord ers represent a subg ro up wit h signifi-
ca n tly lowered CS F levels of 5-HlAA. Among this subgrouping the greates t reduction
in CSF 5-H IAA is associa te d wit h uni pola r depression a nd abse n t in bip olar d isorder.
Add it ion a l st udies report a di st inct ion be tween vio len t ve rsus nonviolent suicide with
the lowest levels associa te d wit h vio lent suicide. This observation is d ifficult to
in terpre t; non et heless it has been su ggest ed by on e reviewer th at " since th e se lectio n
of su icide met ho d is heavily dep end ent on ava ilability a nd mod el ing, it is probable
that th e associa t ion is actually with the ser iousness of in ten t or medi cal let hali ty of
the meth od (13). " In addit ion to th e st ud ies focu sing on met abolit e levels, five of
seven st ud ies have report ed adecrease in 5-HT or 5-H IAA levels within th e brain of
suicide vict ims or suicide at tempter s (12) . The reduced levels were found local ized to
the bra inst em with only one st ud y reporting red uct ions in higher co rt ica l ce n ters.
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The reason for th e di scr epancies between region s a re unknown. One poss ible
expla na t ion is that br ainst em levels may reflect changes at th e level of serotonin cell
bodies, wh ereas co r t ical measures indicate som e as pec t of te rmi na l activity in which
bas al levels are lower by com pa rison.
It is difficult to address th e data discrepan cies between th ose stud ies based on
th e purely depressed versu s th e sui cid e victim. There are seve ra l possible, but
unproven expla na t ions. First , reducti on s in br ain se ro to nin may vary in magnitude
between th e depressive a nd suicidal states such th at low CSF levels are not detected
in th e form er, perhaps du e to th e limit ed se ns itivity of th e assay. Second, indices of
serotonin may be transitory in nature and fluctuate acco rd ing to diet , time of day, e tc .
Third, th e trauma of sui cid e may be associat ed with met ab olic alterations that a re
unrelated to th e et iology of th e depressive illn ess. In fact , given th e di stinctions
between violent ve rs us non violent method s of su icide, th e suicide even t it self may be
a n important a nd undefin ed va riable in th e findings. An ad d itio na l con cern lies in
int erpreting th e anatomical finding of lowered se ro to n in con ten t in the brains of
sui cid e victims. There is some crit icism that th e serotonin being assayed ma y be in
lon ger-t erm storage; th erefore the fun ctional importan ce may be uncl ear ( 13).
Further, an a lte rat ion of th e level of se ro to nin does not necessarily imply a cha nge in
th e conce n t rat ion of avail abl e or fun cti on all y effec tive sero tonin. For exam ple, a
lowering of neuronal serotonin may be com pe nsa ted by a n incr ease in the number of
post-synaptic receptors or an alt eration in the release mech anism of 5-HT fro m th e
neuronal pool. In reviewing th e lit erature, stud ies do not ap pear to have addressed
th e crit ica l qu estion conce rn ing a lte ra t ions in se ro tonin re lease (i.e. functionaI 5-HT)
as a conse q ue nce of depression . Desp ite th ese crit icisms, th e dat a do suggest th at
th ere is an overall change towards a lower se ro to nine rg ic signal in those individuals
attempting suicide.
PLASMA TRYPTOPHAN
Since th e availability of tryptophan is th e rate-limiting fact or in th e syn thesis of
neuronal serotonin, there have been numerous investigations conce rn ing th e conce n-
trations of plasma tryptophan in un medi cated depressed patients. This wor k is bas ed
on th e pr emise that a reduction in ava ilable t ryptophan , possibly becau se of excessive
peripheral metabolism , may underlie th e reducti on in 5-HT measured in the brains
of some depress ed patients (1,13) . The data conce rn ing th e levels of plasm a trypto-
phan are conflict ing, although some studies do report a decr ease in plasm a t rypto-
ph an (14).
A more definitive finding is th e obse rva t ion th at normal cont rol subject s
demon strate a positive co rre la t ion between basal levels of plasm a t ryptopha n and th e
5-HT metabolite 5-HIAA wh ereas depressed patients do not ( I) . In other words, in
th e depress ed patient a n increase in th e substrate for se ro tonin (trypt ophan ) is not
correla ted with an incr ease in serotonin end-produc t (5-HIAA) in plasma. The lack of
corre la tion may sugges t th at some depressed patients abnormally met abolize trypto-
ph an in peripheral organ syste ms, th ereby altering th e C IS cont ent of serotonin .
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However, firm conclus ions a re com plica te d by t he fact th at t rypt opha n may be
sequest ered (i.e . in liver a nd mu scle tissu e) a nd th e exact origin of plas ma 5-H IAA is
unknown. Several studies have shown that large doses of t ryp toph an result in lower
plasma levels of tryptophan in some depress ed versu s con t ro l subj ect s (15,16) . This
suggests that in some cases of depression th ere is a mor e ra pid clearan ce of
tryptophan as opposed to an alteration in tryptophan br eakdown . Indeed , subsequent
expe rime n ts have demonstrated that so me depressed patients have increased red cell
transport of tryptophan and, wh en com pa red to normal con trols, show a great er d rop
in arterial versus venous levels of trypt ophan ( 17, 18). Thus, one interest ing possib ilit y
sugges ts that incr eased peripheral uptak e and clearan ce of tryp toph an cont ribu tes to
th e neuronal deficien cy of serotonin in depression .
The above findings support th e se ro to nin deficien cy hypothesis of depression a nd
are corrobora te d by obs ervations th at alte ra t ions in th e ava ilability of t ryp tophan, or
5-HT itself, influen ce th e mood of depressed individuals (20,2 1,22). In fact , one
reviewer suggests that " the mo st pervasive evide nce for th e ro le of 5-HT in mood
disorders is the effec t oflowering brain 5-HT con centration in depressed pa tien ts a nd
normals (I). " Inhibition of se ro tonin synthesi s, throu gh the ad m inist ra tion of
p-chlorophenylalanine, has been shown to rapidly induce a recu rren ce of the dep res-
sive episode in patients recovering from depression ( 19) . Further, 15 of2 1 a n tide pres-
san t-t re a te d depressed patients who received a t ryptophan -free d iet showed a
subs ta n t ia l incr ease in depressive sym pto ms (20) . However, t his sa me parad igm
improved the symptoms of 14 of 22 untreated depressed individ ua ls. T his la tt er
finding is a direct challe nge to th e th eory th at too little serot onin underl ies th e
continuation of depressive symptoms.
One crit ical factor that limits th e usefulness of tryptophan-depl etion studies
concerns th e fact that uptake of tryptophan is not limited to se ro to ninerg ic neu rons
and th erefore plasma tryptophan may refle ct variations in peripheral metabolism
onl y. As well , depl etion of tryptophan in normal individuals has been shown to have a
mood-elevating effec t (21) . The differential effec t of se ro to nin depl e tion in normal
versu s depressed individuals sugges ts that additional factors alte r th e manifest at ion s
of serotonin depl etion within th e eNS. In other words, th e deple tion of 5-HT in
normal and depressed individuals results in oppos ite mo od outco mes that imply
differences in brain processing, perhaps because of variability of recept or-med ia ted
eve n ts or serotoninergic neuronal release mechanism s.
Bas ed on th e premise that a reduction in tryptophan has a mood-l owering effect
in some depressed patients, administration of tryptophan ha s been attempt ed as
th erapeutic treatment in depression. Unfortunately , tryptophan has rarely been
found to eleva te mood in depressive illn ess (11 ,19). This appears to challe ng e th e ro le
of serotonin in depression exclusive ly in terms of a pr ecursor deficiency. Giv en th e
th erapeutic ineffectiveness of tryptophan alone, it is al so difficult to resolve th e
beneficial ac tion of some antidepressants whi ch are com mo nly th ou ght to rais e
available se rotonin. Perhaps exogenous tryptophan requires met ab olic processing
and neuronal release mechanisms that are impaired in th e depressed and which may
be bypassed by the ac t ion of antidepressants. Sp ecifically, many a n t ide pres sa n ts block
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eit her the re-uptak e or degrad ation of endoge no us serotonin ind ependent of neuro-
nal pr ocessing.
While tryptophan alone has lit t le th era peu tic effec t, tryptophan administration
does enha nce th e effe ct iveness of some ant idepressants (2,22). For exa m ple, the
effect iveness of MAO inhibitors is pot en t ia ted by tryptophan administration in some
pa ti ents. One in te r pre ta tion is th at req uire ments for t he tryptophan a re incr ea sed in
th e drug-treated sta te a nd a re un related to th e e tiology of th e illness . That both
MAO inhibitors a nd tryptophan ac t to incr ease ava ila ble serotonin supports the
th eory th at se ro to nin deficien cy is a ca usal factor in some forms of depression .
There a re also numerou s rep orts th at lith ium ca rbo nat e improves th e ac t ion of
a nt idepressants in a number of pat ien ts (50%) who fa il to respond to a nt ide pres sa n t
treat ment alone (2,22). Several authors suggest that lith ium may al so ac t to incr ease
th e effec tiveness of serotonin t ransmission. BrieAy, levels of neuroendocrine hor-
mo nes a re used to eva luate the ac t ivity of the seroto nin system as 5-HT is known to
pot entiat e th e release of hormon es throu gh it s den se innerva t ion to the hypothala-
m us. Usi ng this mod el , lithium has been show n to incr ease pat ient a nd rod ent
respon siveness to sero to nin a nd /or tryptophan as reflec ted by an incr ea se in endo -
cri ne hormon es such as prolac tin and cor t isol (24 ,25 ,26). Although th e use of
neuroendocrine parameters does provide a window to brain function , th e pr esen ce of
a d irect casual rela tionship is unclear. For example, th e hypothalamic-pituit ary axis
is modula ted by numerou s neuroact ive che mica ls a nd ph ysiologica l sta te s. Therefor e,
lithium may ac t ind ependent of se ro to nin to ac t iva te t he hypothal am ic ax is or
pot entiat e exci tatory medi ators (i.e. re leasing factors) of this syst em.
In sum, t he a na lysis of basal plasm a t ryp tophan levels is inconclusive to dat e.
However, whe n compared to normal con trols, increases in tryptophan do not corre-
la te wit h increases in plasma 5-HT metab olit e levels in som e depressed patients. The
discr epan cy between seroto nin subs trate (tryptopha n) and metabolit e (5-HlAA) may
a rise from altera tions in met ab olism or incr eased clearance, perhaps by non-
neuronal organ syste ms . A reduction of tryptophan levels lowers t he mood in some
depressed patients a nd eleva tes mo od in normal con t ro ls. Converse ly, eleva t ions in
t ryptophan levels have little, if a ny, mood a ltering action in the treatment of
depression . This lat ter obse rvat ion cha lle nges the explana t ions of dep ression sole ly in
ter ms of se rotoni n deficien cy. However, in part , many ant idepressants do appear to
enhance t he actions of sero to nin alt ho ug h th e specificity of this effec t is unclear.
Collec t ively, th ese studies point to an overall decrease in seroto nin as a ca usal, ye t not
exclusive, factor in so me forms of depressive illn ess.
~EROTONIN tJPTAKE SITES AND RECEPTORS
An other a pproach for assessin g the se rotonin system has involved the measu re-
ment of se ro tonin receptor conte nt in post-mort em brain tissu e a nd blood platelet s.
The following dis cu ss ion is subdivide d into two sec t ions to cla r ify the distinction
between th e data pertaining to th e uptak e of sero to nin versus th at re lated to 5-HT
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receptors whi ch mediate th e ac t ions of se ro to nin. The first section will review
expe rimen ts whi ch involve th e assay of ligand binding to 5-HT uptake sites on blood
plat elet s a nd se roto nine rg ic neuron s. It is important to clar ify that neuronal seroto-
nin uptak e sit es a re distribut ed on sero to nine rg ic presynapt ic terminals. Therefore, a
reducti on in 5-HT uptake sites refers only to a loss of serotonin storage (presynapt i-
ca lly) as opposed to a direct loss in post synaptic effect. The sec ond section descri bes
alte rat ions in serotonin receptors which a re di stribut ed pr imarily on post syn ap tic
neuron s. These receptors a re found th roug ho u t th e nervou s syste m as well as on
blood platelet s, wh ere th ey medi at e th e actions of se ro to nin. T he serotonin receptor s
are ca tegorized into multiple subtypes based on differential affinity for va riou s
ligands (5,6). Bri efly, th e evolving dat a su ggest th at seroto nin receptor s ca n be
ca tegorized into three major famili es: 5-H T i , 5-HT 2 a nd 5-HT 3• T he 5-HT 1 class is
rep ort ed to be het erogen eous a nd subd ivide d into th e 5-HT If\ ' 18, ic and II) receptor s.
The ori ginal pharmacological distinctions have been confir med by studi es th at have
shown that eac h sub type is unique on th e bas is of a na to mica l distribut ion, signa l
transduction, ph ysio logical behavior and mo lecul ar com position.
S erotonin Uptake Sites
Early stud ies report cont rove rs ia l evide nce for a reduct ion in th e number of
serotonin uptak e sit es both in plat elet s and br ains of patients wit h major depression
( 12,27,28,29,30). These results are com plica te d inpart by recen t indicat ion s th at
several of th e ligands used (e .g. im pramine) recogni ze receptors of ot he r neurotra ns-
mitters a nd th erefore lack 5-HT binding spe cificity.
Expe r ime nts with more select ive ligands (e.g . pa roxe t ine) have indicat ed a
significan t reducti on in th e den sit y of 5-HT uptak e si tes both in plat elet s a nd br ain
tissu e of depressed patients wh en com pare d to age-matched con t rols (28) . Co ns iste n t
with th e se ro to n in deficiency hypothesis, a loss of plat elet 5-HT upta ke would be
expected to result in a loss of available seroto nin to th e nervous sys te m . In th e brain ,
a reducti on in 5-HT uptak e would be expecte d to increase the a mo unt of ava ilable
se ro tonin in th e synaptic cle ft. Indeed , th e a n tide pressan t fluoxc tine is th ou gh t to
exer t its effec ts by blocking th e sa me serotonin uptak e mech anisms. It is cu rious tha t
th ese same site s a re reduced in th e depressed patient. This a lso challen ges th e
proposition that too litt le se roto nin is a ca usal fact or in depression. One reviewer
sugg es ts that th e decr ease in se rotonin uptak e site s may reflect a com pe nsa tory
mechanism wh ereby a primary reduction in 5-HT induces a decr ease in serot onin
uptake at se rotonine rg ic te rm ina ls in order to incr ease available 5-HT in th e synap tic
cleft (27) . This interest ing pr opo sition wou ld sugges t th at , when challe nge d by a
reducti on in 5-HT, th e brain 's own mech anism for maint ai ning ava ilable serotonin
mimi cs th e act ion of some drugs by decr easin g th e a mo un t of 5-HT avai labl e to th e
post synaptic neuron. It remains to be resolved wh ethe r the noted loss of 5-HT
neuronal uptake signi fies a primary deficit or a secondary com pe nsa tory response to
se ro to nin loss.
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A review of the lit erature pertaining to th e 5-HT 2 rec eptor found t hree of four
stud ies which report ed a n increase in 5-HT 2 sites in t he cor te x of sui cid e victims
(3 1,32,33,34) . Similarly, one study has repor ted an increase in pr efrontal 5-HT 2
rece pto rs in th e brains of depressed patients (35) . T hese findings suppo rt the
sero to nin deficien cy mod el of depression whereby a re d uct ion in serotonin results in a
su bse q ue n t up-regul at ion of postsynaptic 5-HT 2 receptors. Conversely, 5-HT2 recep-
tor s a re down-regul ated by a va rie ty of a n tide pressants, including MAO inhibitors
a nd 5-HT uptak e inhibitors (e.g. impramine). Furt her, high affinity 5-HT2 a n tago-
nists (e .g, mianserin) whi ch have sig nifica nt clini cal va lue , have a lso been shown to
se lec tive ly decr ease 5-HT 2 receptors (36,3 7) . This docs not im ply that drug treatment
directl y induces receptor down-regul a tion. Theoreti cally, antidepressants may in-
du ce 5-HT 2 receptor down -r egul ation as a n indi rect conseq uence of incr easing
avai lable se roton in.
It is unclear, how ever, wh ether intact se rotonine rg ic neu rons are necessary for
th e down-regul ation of associa ted receptors (38,39). In fact , selec t ive lesions of
se ro to nine rgic neuron s does not cons iste n tly ca use 5-HT 2 recep tor up-r egula t ion.
Lesion s of ca techola mine -co nta ining neuron s (e.g. basal fore brain) do , however,
result in receptor up -r egul ation of 5-HT 2 receptors (39) . It is possible, th erefore, th at
alte ra t ions in 5-HT 2 receptors depend on interact ion s wit h other t ran smitt er path-
ways th rou gh unknown mech anism s. In fac t, a rece n t pub lication reports a reducti on
in t ryos ine hydroxylase, th e rat e-limi t ing enzyme of ca te chola mine syn the sis, in
depression (40) .
In cont ras t to it s an t ide pressant ac t ion, it is in terest ing to note th at elec t rocon-
vulsive shoc k treatment ca uses an up-regula t ion of 5-HT2 receptors (41). Further,
th is effect is se lec t ively dependent on intact sero toninergic neurons (38) . It mu st be
noted , however, th at electroconvulsive shoc k th erapy has widespread effects which
may have value indep endent of it s ac tion on th e sero toni n syst em.
Com pa re d to t he 5-HT 2 recep tor class, studies of the 5-HT, receptors are more
pr eliminary. In part , th e difficulty in definin g th e ro le of 5-HT, receptors in
depression reflect s th e lack of se lec t ive ligands for this receptor class. And, unl ike th e
5-HT 2 receptors whi ch occupy a post synaptic position , th e 5-HT, recep tors are found
post synapticall y and pr esynaptically on se ro to nine rg ic neu ron s (a utorece ptors) and
nonserotoninergic neurons (h ereroreceptors) (5,6). Earl y stud ies whic h did not
discriminate between 5-HT 1 receptors fail ed to find a reducti on in total receptor
conte nt (31,45,46). However, se lec t ive investigation of th e 5-HT'A recep tor have
shown a sig nifica n t incr ease (30%) in receptors in th e brains of suicide victims when
co m pa re d to con t ro ls (47 ,48).
The receptor binding ex pe rime n ts demon st rate that dep ression is associated
with a reducti on of se ro to nin uptak e sites a nd a n up-regul a t ion in some classes of
5-HT receptors. The challenge is to integrat e t he independent findings int o a
uni fyin g hypothesis . One in te rpre tat ion would sugges t that a pr imary loss in serot o-
nin itself induces com pe nsa tory alterat ions in receptor cont en t wh ereby postsynaptic
10 J EFFERSO N J O URNAL OF PSYCHIATRY
sit es up-regul ate and pr esynaptic 5-HT uptak e sites down-regul at e. The net effec t of
suc h a dynamic would be to increase available sero to nin (via uptak e down-regul ation)
wh ile a m plifying post synaptic effect ive ness (via post synapt ic up -regu lation). Aga in ,
th ese even ts would signify a n adapt ive receptor resp on se to a deficiency in se ro tonin.
An a lte rn a t ive hypothesis postulates that a lte ra tions of 5-HT rece ptors repre-
se n t a primary or initiating fact or , as opposed to th e com pe nsatory response. This
would imply that an incr ease in net seroton in transm ission med iat es depressive
sym pto ms du e to excessive se ro to nin at th e synapse as well as an a mplificat ion of th e
signa l a t th e post synaptic site . As a conse q ue nce, levels of sero to nin and its metabo-
lit e may be expec te d to drop.
The crit ical di stincti on between th ese hypotheses is whe t he r th e pr imary defect
occurs pr e or post synaptically. The latter mod el would im ply that incr eases in
seroto nin ac t ivity me d ia te depression throu gh an a ltera t ion in serotonin receptors.
Severa l lin es of evide nce pr esent ed pr eviou sly con t ra d ict th e serotonin deficien cy
hypothesis pr esent ed first a nd support ed th e latt er conce pt th at depression ma y be
associa te d with excess ive se roto nin tran smission and /or a ltered post synap tic ac t ivity.
For exam ple, some a n t ide pre ssan ts exe rt th eir effects by bloc king and /or down-
regul ating post synaptic 5-HT receptors. In add it ion, th e fact that serotonin dcn erva-
tion fail s to a lte r th e conce n trat ion of so me receptors suggests that up-regulation
occurs exclus ive to reductions in ava ilable se ro to nin.
One study has attempted to di stingui sh bet ween th e ro les of pr e versus
post synaptic eve n ts in a nimal mod els of de pression (5 1). Dep ression was induced by
th e ad minist ra t ion of5-HT or tet rab en azin e a nd defined in terms of degree of animal
acti vity. In th e "de pressive" sta te, specific uptake blockers of serotonin (e.g. Auox-
et ine) were found to potentiate th e depressive sym pto ms substant ia lly (200 %). The
incr eases in depressive behavior were corre la ted with incr eas es in brai n 5-HIAA, th e
principl e se ro to nin metabolite. In cont ras t, post synaptic blockad e of serotonin recep -
tors (e .g. methylsergid e) almost com ple te ly abo lishe d the depressive action of 5-HT.
Simila rly, se ro to n in-ind uce d depression was abo lishe d by some a nt idepressants (e .g.
mianserin, imipramine) which exe r t th eir effec ts by block ing se ro to nin pos tsynapti-
cally. Taken together, th e data imply th at depression may be mediat ed post synap t i-
ca lly a nd induced by excess transmission of se ro to nin a t th e syna pse .
T o furthe r defin e th e func t iona l roles of 5-HT 1A receptors in depress ion ,
expe rime n ts have a na lyzed ph ysiological respon ses associa ted with 5-HT 1A recep tor
acti vation. As mentioned , neuroendocrine paramet ers a re freq ue n t ly mon itored as a
fun ctional indicator of serotonin. ac t ivity. Compared to human controls, dep res sed
patients show a ttenuate d hypothalamic and neuroendocrine (e .g . ACT H, cort isol)
responses to select ive 5-HT 1A agonists (49,50) . This findi ng was somewhat sp ecific for
depression wh en com pa re d to individual s with bipola r d isord er or obs essive-
com pulsive illn ess. Thus, alteration s of 5-HT 1A receptor a nd /or it s signa l transduc-
tion pathway appear to playa specific rol e in depression. The importan ce of this
observation is that the depression -associated changes with in th e se ro ton in system
may ex te nd beyond alterations in 5-HT conten t a nd involve di minish ed fun ctional
effec t iveness.
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In su m m ary, there is subs tan tial evidenc e to suggest that depress ion is associ-
a te d wit h a reduction in serot onin upt ak e sites as we ll as a n increase in some cla sses
of sero to n in receptors. It is not kn own whe ther the receptor alterations represent a
pri mary d efect or a secondary consequence of lowered se ro to nin conte nt. T he
serotonin theory has yet to uneq uivocall y assign a cause versu s effec t rol e to th e man y
va riables kn own to be a lte red in depression. Although th e underlyin g dynamics a re
unresolved, t he lit e ra ture typi call y defi nes the serotonin syst em as being " de ficie nt"
in affec t ive illn ess. This d escript ion can be int erpre ted as either a reduction in
se ro tonin a nd / or a loss in receptor-mediated signal.
CONCLUSIONS AND FUTU RE DIRECTIONS
T he ro le of se ro to ni n in affect ive illn ess is based in part on th e following
pathophysio logical changes found in depression : I) decr eased brainst em 5-HT a nd / or
5-H IAA, 2) increased plasma tryptophan clearance, 3) tha t re d uc tion in tryptophan
ind uces depressive episodes in th e depressed , 4) t hat sero tonin uptake sites down-
regula te while so me classes of serotonin recepto rs up-regu la te, 5) that neuroendo-
crine ac tivi ty is su brespo nsive to serotonin stim ulation and 6) that many effect ive
an t ide pressan t th erapies increase sero toninergic act ivity . To dat e , no un ifyin g th eory
can accou n t for th e obse rved changes in the seroto nin system as e ithe r a cause or
conseq ue nce of depression .
The involvem en t of o the r transmitt e r sys te ms in depression has not been
addressed due to the limited sco pe of this review. It is probably inaccu ra te to assume
that depressive illness involves a se lec tive im pairment within th e serotoninergic
system. In fac t, th e bro ader descr ip ti on of depress ion as an amine d eficien cy has been
expa nded based on curre n t concep ts wh ich em phasize t he dependent interrelation-
ship between neurotransmitter sys te ms (52,53,54,57). T his int eraction is based on
well-documented reports that mult ipl e transmitt e rs a re co- localize d wit hin the same
neuron. Moreover, the ac t ions of distinct neurotransm itt e rs a re co up led at th e level
of transducti on . For exam ple , se roto nin utili zes G pro teins, second m ess en gers and
ion channe ls whi ch are a lso ac tivate d by other ne uro transmitt ers and peptides. In
o the r word s, se ro to nin a lte rs neu ronal res po ns ive ness th rough its shared interaction
with o the r neurotransmitt ers/peptides. Thus, th ere is an ever increasing challe nge
to th e d escript ion of " de ficits" in terms of sing le t rans mi tter sys tems. Further,
depression may represent an alte ra tio n in sig na l transduct ion suc h that serotonin is
susce pt ible to dysfunction th rough it s associa t ion with th ese second messengers.
It is a lso importan t to not e t ha t changes withi n th e serotonin axis do not account
for the widespread pa tho logical changes foun d in d ep ressive illness . For exa mple,
d epression is associa te d with the following abnormaliti es: lowered Na " -K+ ATPase
ac t ivity, lowered Ca t t -Mg" " AT Pase ac tivity, lowered adrene rg ic beta2 recep tor
ac t ivity a nd increased ad re ne rgic-a lpha2 receptor number/ activity (55) . Based on
t he se obse rva tions, th ere is st ro ng impl ication for th e ro le of som e abno rmality with
wides pread pathogenic conseq ue nces in d ep ressive illn ess. Sim ila rily, there are few
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referen ces in th e lit erature to mech anism s whi ch may induce or initiat e se ro to nin
dysfunction in depression.
The description of depression as a se ro to nin "deficiency" has follow ed th e
di recti on of basic research from a focu s on transmitter deficiencies, to impaired
signaling mechanism s. The em phas is on ce llula r fun cti on com plica tes the interpret a-
tion of data as it relates to depression. For exam ple, th e level of receptor content docs
not necessa rily correla te with degree of func tion as a single receptor has been shown
to a m plify signa ls through th e ac t iva tion of m ultiple G prot ein mo lecules (56 ,57).
Ther efor e, a future challe ng e will be th e translation of basic resea rch to behavioral
significa nce . Sp ecificall y, in order to underst and th e ro le of serotonin in depression ,
fu tu re s tud ies a re need ed to det ermine th e in terrelation sh ip between se rotonin a nd
other physiological mediators th at a re a lso known alte re d in dep ression .
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